Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitumprotimut-T (FavId) + GM-CSF vs Placebo + GM-CSF in Follicular Lymphoma
NCT00089115Phase 3Terminated
- Sponsor
- Favrille, Inc.
- Start
- Jul 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in follicular lymphoma (FL) comparing Mitumprotimut-T + GM-CSF with Placebo + GM-CSF (2 arms). Primary endpoint: Time to Progression. Started Jul 2004; status: terminated.
02
Drugs
mitumprotimut-T
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00089115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089115.